Brief: Radiopharm Theranostics Ltd Co Partners With Starpharma On Research And Option Agreement To Develop Novel Radiotherapy Asset
30/09/2025 11:17
Sept 30 (Reuters) - Radiopharm Theranostics Ltd RAD.AX: RADIOPHARM THERANOSTICS LTD: CO PARTNERS WITH STARPHARMA ON RESEARCH AND OPTION AGREEMENT TO DEVELOP NOVEL RADIOTHERAPY ASSET Source text: [ID:n0001213900-25-093349] Further company coverage: RAD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsBrief: Radiopharm Theranostics Advances To Cohort 3 In 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial
Brief: Radiopharm Theranostics And Siemens Healthineers Sign Clinical Supply Agreement For Rad101 In The U.S.
Brief: Radiopharm Theranostics Says RAD And Siemens Sign Clinical Supply Agreement For Rad101
Brief: Radiopharm Theranostics Doses First Patient In Phase 1/2A Clinical Study Of Betabart
Brief: Radiopharm Theranostics Says Co Increases Ownership In Radiopharm Ventures To 87.5%